lorazepam has been researched along with promethazine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 15 (53.57) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Collignon, P; Oury, M | 1 |
| Dodson, ME; Eastley, RJ | 1 |
| Fitzal, S; Groll-Knapp, E; Länger, W; Riegler, R | 1 |
| Benson, AB; Berry, W; Buzdar, AU; Calzone, K; Cody, R; Esparza, L; Natale, R; Sheehan, T | 1 |
| Aldenhoff, JB; Friege, L; Göder, R; Grohmann, R; Treskov, V | 1 |
| Duggal, HS | 1 |
| Adams, C; Alexander, J; John, T; Mol, C; Philip, J; Tharyan, P | 1 |
| Blake, D; Chelonis, JJ; Dornhoffer, J | 1 |
| Alexander, J; Allen, MH; Huf, G | 1 |
| Basu, D; Jhirwal, OP; Kulhara, P | 1 |
| Chandra, PS; Ranjan, S | 1 |
| Alexander, J; Allen, MH; Huf, G; Raveendran, NS | 1 |
| Adams, CE; Coutinho, ES; Huf, G | 1 |
| Bak, M; Marcelis, M; van Os, J | 1 |
| De Meyer, G; Dornhoffer, JL; Pauwels, G; Van de Heyning, PH; Vanspauwen, R; Weerts, AP; Wuyts, FL | 1 |
| Amini, A; Asadollahi, S; Habibi, T; Heidari, K; Kariman, H; Mansouri, B; Shahrami, A | 1 |
| Alexander, J; Allen, MH; Gandhi, P; Huf, G | 1 |
| Aggarwal, N; Kataria, D; Prakash, R; Prasad, S | 1 |
| Bak, E; Bak, M; Bervoets, C; Bienkowski, P; De Fruyt, J; Dom, G; Drukker, M; Fiorillo, A; Frydecka, D; Misiak, B; Preuss, WU; Samochowiec, A; Samochowiec, J; Sampogna, G; Weltens, I | 1 |
| Osser, DN; Stetson, SR | 1 |
9 review(s) available for lorazepam and promethazine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Haloperidol plus promethazine for psychosis induced aggression.
Topics: Aggression; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Promethazine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic | 2005 |
Haloperidol plus promethazine for psychosis-induced aggression.
Topics: Aggression; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic | 2009 |
[Haloperidol plus promethazine for agitated patients--a systematic review].
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Randomized Controlled Trials as Topic | 2009 |
[Rapid tranquillisation; review of the literature and recommendations].
Topics: Aggression; Benzodiazepines; Conscious Sedation; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Midazolam; Olanzapine; Practice Guidelines as Topic; Promethazine; Psychotic Disorders; Time Factors; Treatment Outcome | 2011 |
Haloperidol plus promethazine for psychosis-induced aggression.
Topics: Aggression; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Midazolam; Promethazine; Psychomotor Agitation; Psychotic Disorders; Randomized Controlled Trials as Topic; Restraint, Physical | 2016 |
The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.
Topics: Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Midazolam; Olanzapine; Promethazine; Psychomotor Agitation; Psychotic Disorders; Treatment Outcome | 2019 |
Psychopharmacology of agitation in acute psychotic and manic episodes.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Mania; Olanzapine; Promethazine; Psychomotor Agitation; Psychopharmacology; Psychotic Disorders | 2022 |
7 trial(s) available for lorazepam and promethazine
| Article | Year |
|---|---|
Comparative study of two long-acting tranquillizers for oral premedication.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lorazepam; Middle Aged; Preanesthetic Medication; Promethazine | 1978 |
[Premedication with flunitrazepam, lormetazepam or pethidine-promethazine. Psychometric study of subjective conditions].
Topics: Adult; Amnesia; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Depression; Emotions; Flunitrazepam; Humans; Hypnotics and Sedatives; Lorazepam; Meperidine; Middle Aged; Preoperative Care; Promethazine; Psychometrics | 1983 |
Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Middle Aged; Nausea; Promethazine; Severity of Illness Index; Vomiting | 1994 |
Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine.
Topics: Antipsychotic Agents; Drug Therapy, Combination; Emergencies; Emergency Service, Hospital; Female; Haloperidol; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Male; Mental Disorders; Promethazine; Psychomotor Agitation; Time Factors; Violence | 2004 |
Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
Topics: Adolescent; Adult; Double-Blind Method; Female; GABA Modulators; Histamine H1 Antagonists; Humans; Lorazepam; Male; Meclizine; Muscarinic Antagonists; Promethazine; Scopolamine; Semicircular Canals; Space Motion Sickness; Treatment Outcome; Vestibular Function Tests | 2004 |
Pharmaceutical countermeasures have opposite effects on the utricles and semicircular canals in man.
Topics: Adult; Antiemetics; Female; Humans; Lorazepam; Male; Meclizine; Middle Aged; Promethazine; Reflex, Vestibulo-Ocular; Saccule and Utricle; Scopolamine; Semicircular Canals; Space Motion Sickness; Vestibular Function Tests | 2012 |
Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo in the emergency department: A double blind, randomized clinical trial of efficacy and safety.
Topics: Double-Blind Method; Female; Humans; Injections, Intravenous; Lorazepam; Male; Middle Aged; Nausea; Promethazine; Vertigo | 2014 |
12 other study(ies) available for lorazepam and promethazine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Use of injectable lorazepam in preparation for cardiac catheterization].
Topics: Anti-Anxiety Agents; Cardiac Catheterization; Drug Evaluation; Humans; Injections, Intramuscular; Lorazepam; Meperidine; Premedication; Promethazine | 1976 |
Association of paroxetine with suicide attempt in obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Humans; Lorazepam; Male; Methotrimeprazine; Obsessive-Compulsive Disorder; Paroxetine; Promethazine; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted | 2000 |
Neuroleptic malignant syndrome precipitated by promethazine and lorazepam.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Histamine H1 Antagonists; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Promethazine; Psychomotor Agitation; Substance Withdrawal Syndrome | 2001 |
Limitations of rapid tranquillisation trial.
Topics: Antipsychotic Agents; Central Nervous System Depressants; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Mental Disorders; Promethazine; Treatment Outcome | 2005 |
Drug combinations for rapid tranquillisation.
Topics: Antipsychotic Agents; Central Nervous System Depressants; Cost-Benefit Analysis; Drug Therapy, Combination; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Promethazine | 2005 |
Meditation induced psychosis: Case report.
Topics: Adult; Antipsychotic Agents; GABA Modulators; Haloperidol; Humans; Lorazepam; Male; Meditation; Promethazine; Psychotic Disorders; Risperidone | 2018 |